OpenWorld plc - Russell Investments Global High Dividend Equity C EURORegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -3.0 | 14.7 | -0.9 | 2.6 | 6.8 | |
+/-Cat | -4.9 | -3.5 | -0.2 | -4.6 | -3.0 | |
+/-B’mrk | - | -5.6 | -7.8 | -2.1 | -5.0 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 22/11/2024 | EUR 2406.79 | |
Day Change | 1.23% | |
Morningstar Category™ | Global Equity Income | |
ISIN | IE00B4PPRT53 | |
Fund Size (Mil) 22/11/2024 | USD 302.90 | |
Share Class Size (Mil) 22/11/2024 | EUR 0.15 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 01/10/2021 | 2.71% |
Investment Objective: OpenWorld plc - Russell Investments Global High Dividend Equity C EURO |
The Fund aims to provide long-term capital appreciation from a portfolio comprised predominantly of Equities and Equity-Related Instruments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
William Pearce 31/12/2019 | ||
Inception Date 14/05/2010 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for OpenWorld plc - Russell Investments Global High Dividend Equity C EURO | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
Russell Inv US Dollar Cash II SW... | 2.38 | |
Johnson & Johnson | Healthcare | 1.43 |
Novartis AG Registered Shares | Healthcare | 1.43 |
PepsiCo Inc | Consumer Defensive | 1.43 |
Microsoft Corp | Technology | 1.39 |
Increase Decrease New since last portfolio | ||
OpenWorld plc - Russell Investments Global High Dividend Equity C EURO |